Publication Cover
Endothelium
Journal of Endothelial Cell Research
Volume 3, 1995 - Issue 2
4
Views
3
CrossRef citations to date
0
Altmetric
Original Article

Estradiol Specific Binding by Endothelial Cells and its Limited Effect on Von Willebrand Factor Expression

, , &
Pages 131-139 | Received 11 Nov 1994, Accepted 09 Jan 1995, Published online: 13 Jul 2009

References

  • Alperin J. B. Estrogens and surgery in women with von Willebrand's disease. American Journal of Medicine 1982; 73: 367–371
  • Beckman W. C., Hudspeth D. A., Golding T., Hubbert L., Akkerman J, Korach K. S. Biomodal nuclear estrogen receptor binding: synchrony in athymic mouse uterus and human breast tumor xenografts. Endocrinology 1989; 124: 265–266
  • Bennett B., Ratnoff O. D. Changes in antihemophilic factor (AHF, factor VIII) procoagulant activity and AHF-like antigen in normal pregnancy, and following exercise and pneumoencephalography. Journal of Laboratory and Clinical Medicine 1972; 80: 256–263
  • Berthois Y., Katzenellenbogen J. A., Katzenellenbogen B. S. Phenol red in tissue culture medium is a weak estrogen: implications concerning the study of estrogen-responsive cells in culture. Proceedings of the National Academy of Sciences USA 1986; 83: 2496–2500
  • Blombäck M., Eneroth P., Landgren B -M., Lagerström M., Anderson O. On the intraindividual and gender variability of haemostatic components. Thrombosis and Haemostasis 1992; 67: 70–75
  • Booyse F. M., Osikowicz G., Feder S. Effects of various agents on ristocetin-Willebrand factor activity in long-term cultures of von Willebrand and normal human umbilical vein endothelial cells. Thrombosis and Haemostasis 1981; 46: 668
  • Bradley L. A., Franco E. L., Reisner H. N. Use of monoclonal antibodies in an enzyme immunoassay for factor VIII-related antigen. Clinical Chemistry 1984; 30: 87–92
  • Brinkhous K. M., Read M. S., Reddick R. L., Griggs T. R. Pathophysiology of platelet-aggregating von Willebrand factor: applications of the venom coaglutinin vWF assay. Annals of the New York Academy of Sciences 1981; 370: 191–204
  • Chan S. Y. W., Chan P. H., Ho P. C., Yam A. Factor VIII-related antigen levels in normal pregnancy and puerperium. European Journal of Obstetrics, Gynecology, and Reproductive Biology 1985; 19: 199–204
  • Clark J. H., Peck E. J. Biology and Pharmacology of estrogen receptor binding: relationship to uterine growth. Receptor and Hormone Action, B. W. O'Malley, L. Birnbaumer. Academic Press, New York 1978; Vol 2: 1–31
  • Colburn P., Buonassisi V. Estrogen-binding sites in endothelial cell cultures. Science 1978; 201: 817–819
  • Cornea-Rotter R., Mariash C. N., Rosenberg M. E. Loading and transfer control for northern hybridization. Biotechniques 1991; 12: 154–158
  • Cox N. M., Ramirez J. L., Matamoros I. A., Bennett W. A., Britt J. H. Influence of season on estrous and luteinizing hormone responses to estradiol benzoate in ovariectomized sows. Theriogenology 1987; 27: 395
  • Davis V. L., Couse J. F., Gray T. K., Korach K. S. Correlation between low levels of estrogen receptors and estrogen responsiveness in two rat osteoblast-like cell lines. Journal of Bone and Mineral Research 1994; 9: 983–991
  • de Leeuw W. J. F., Slagboom P. E., Vijg J. Quantitative comparison of mRNA levels in mammalian tissues: 23s ribosomal RNA level as an accurate internal control. Nucleic Acids Research 1989; 17: 10137–10138
  • Drouva S. V., Gorenne E., Laplante E., Rerat E., Enjalbert A., Kordon G. Estradiol modulates protein kinase C activity in the rat pituitary in vivo and in vitro. Endocrinology 1990; 126: 536–544
  • Edgell C. J. S., McDonald C. C., Graham J. B. Permanent cell line expressing human factor VIII-related antigen established by hybridization. Proceeding National Academy Sciences USA 1983; 80: 3734–3737
  • Edgell C. J. S., Haizlip J. E., Bagnell C. R., Packenham J. P., Harrison P., Wilbourn B., Madden V. Endothelium specific Weibel-Palade bodies in a continuous human cell line EA.hy926. In Vitro Cellular & Developmental Biology 1990; 26: 1167–1172
  • Feinberg A. P., Vogelstein B. A technique for radio-labeling DNA restriction endonuclease fragments to high specific activity. Addendum. Analytical Biochemistry 1984; 137: 266–267
  • Foster T. L., Casey C. R. Covalent solid phase for enzyme immunoassay. American Clinical Products Review 1988; 1: 32
  • Fuqua S. A. W., Falette N. G., McGuire W. L. Sensitive Detection of Estrogen Receptor RNA by Polymerase Chain Reaction Assay. Journal of the National Cancer Institute 1990; 82: 858–861
  • Fuqua S. A.W., Fitzgerald S. D., Chamness G. C., Tandon A. K., McDonnell D. P., Nawaz Z., O'Malley B. W., McGuire W. L. Variant human breast tumor estrogen receptor with constitutive transcriptional activity. Cancer Research 1991; 51: 105–109
  • Gimbrone M. A. Culture of vascular endothelium. Progress in Hemostasis and Thrombosis 1976; 3: 1–28
  • Godsland I. F., Wynn V., Crook D., Miller N. E. Sex, plasma lipoproteins, and atherosclerosis: prevailing assumptions and outstanding questions. American Heart Journal 1987; 114: 1467–1503
  • Golding T. S., Korach K. S. Nuclear estrogen receptor molecular heterogeneity in the mouse uterus. Proceedings of the National Academy of Sciences USA 1988; 85: 69–73
  • Greene G. L., Gilna P., Waterfield M., Baker A., Hort Y., Shine J. Sequence and Expression of Human Estrogen Receptor Complementary DNA. Science 1986; 231: 1150–1154
  • Gronemeyer H. Transcription activation by estrogen and progesterone receptors. Annual Reviews of Genetics 1991; 25: 89–123
  • Gruchow H. W., Anderson A. J., Barboriak J. J., Sobocinski K. A. Postmenopausal use of estrogen and occlusion of coronary arteries. American Heart Journal 1988; 115: 954–963
  • Guyton A. C. Human Physiology and Mechanisms of Disease, Fifth Edition. W. B. Saunders Company, Philadelphia 1992
  • Harrison R. L., McKee P. A. Estrogen stimulates von Willebrand factor production by cultured endothelial cells. Blood 1984; 63: 657–665
  • Horwitz K. B., Horwitz L. D. Canine vascular tissues are targets for androgens, estrogens, progestins, and glucocorticoids. Journal of Clinical Investigation 1982; 69: 750–758
  • Howard J. J., Britt J. H. Prostaglandin F-2alpha causes regression of an hCG-induced corpus luteum before day 5 of its lifespan in cattle. Journal of Reproductive Fertility 1990; 90: 245–253
  • Jaffe E. A., Nachman R. L., Becker C. G., Minick C. R. Culture of human endothelial cells derived from umbilical veins. Journal of Clinical Investigation 1973; 52: 2745–2756
  • Karas R. H., Patterson B. L., Mendelsohn M. E. Human vascular smooth muscle cells contain functional estrogen receptor. Circulation 1994; 89: 1943–1950
  • Koehorst S. G. A., Jacobs H. M., Thijssen J. H. H., Blankenstein M. A. Wild type and alternatively spliced estrogen receptor messenger RNA in human meningioma tissue and MCF7 breast cancer cells. Journal of Steroid Biochemistry and Molecular Biology 1993; 45: 227–233
  • Komm B. S., Terpening C. M., Benz D. J., Graeme K. A., Gallegos A., Korc M., Greene G. L., O'Malley B. W., Haussler M. R. Estrogen binding, receptor mRNA, and biologic response in osteoblast-like osteosarcoma cells. Science 1988; 241: 81–83
  • Korach K. S. Estrogen action in the mouse uterus: characterization of the cytosol and nuclear receptor system. Endocrinology 1979; 104: 1324–1332
  • Lindberg U. B., Crona N., Stigendal L., Teger-Nilsson A. C., Silfverstolpe G. A comparison between effects of estradiol valerate and low dose ethinyl estradiol on haemostasis parameters. Thrombosis and Haemostasis 1989; 61: 65–69
  • Lombardi R., Mannucci P. M., Seghatchian M. J., Garcia V. V., Coppola R. Alterations of factor VIII von Willebrand factor in clinical conditions associated with an increase in its plasma concentration. British Journal of hematology 1981; 49: 61–68
  • Mancuso D. J., Tuley E. A., Westfield L. A., Worrall N. K., Shelton-inloes B. B., Sorace J. M., Alevy Y. G., Sadler J. E. Structure of the gene for human von Willebrand factor. Journal of Biological Chemistry 1989; 264: 19514–19527
  • Martinez E., Wahli W. Characterization of hormone response elements. Nuclear Hormone Receptors: Molecular Mechanisms, Cellular Functions, Clinical Abnormalities, M. G. Parker, M. G. Parker. Academic Press. 1991; 125–153
  • Mayadas T. N., Wagner D. D. Von Willebrand Factor Biosynthesis and Processing. Annals of the New York Academy of Sciences 1991; 614: 153–166
  • Migliaccio S., Davis V. L., Gibson M. K., Gray T. K., Korach K. S. Estrogens modulate the responsiveness of osteoblast-like cells stably transfected with estrogen receptor. Endocrinology 1992; 130: 2617–2622
  • Nilsson I. M., Holmberg L., Aberg M., Vilhardt H. The release of plasminogen activator and factor VIII after infection of DDAVP in healthy volunteers and in patients with von Willebrand's Disease. Scandanavian Journal of Haematology 1980; 24: 351–359
  • Packenham J. P. Effect of Estradiol on von Willebrand Factor Expression in Cultured Endothelial Cells. University of North Carolina, Chapel Hill 1992
  • Paganini-Hill A., Ross R. K., Henderson B. E. Postmenopausal oestrogen treatment and stroke: a prospective study. British Medical Journal 1988; 297: 519–522
  • Ponglikitmongkol M., Green S., Chambon P. Genomic organization of the human oestrogen receptor gene. EMBO Journal 1988; 7: 3385–3388
  • Press M. F., Nousek-Goebl N., King W. J., Herbst A. L., Greene G. L. Immunohistochemical assessment of estrogen receptor distribution in the human endometrium throughout the menstrual cycle. Laboratory Investigation 1984; 51: 495–503
  • Rieber A. J., Marr H. S., Comer M. B., Edgell C. J. S. Extent of differentiated gene expression in the human endothelium-derived EA.hy926 cell line. Thrombosis and Haemostasis 1993; 69: 476–480
  • Sarrel P. M. Ovarian hormones and the circulation. Maturitas 1990; 590: 287–298
  • Sullivan J. M., Vander Zwaag R., Lemp G. F., Hughes J. P., Maddock V., Kroetz F. W., Ramanathan K. B., Mirvis D. M. Postmenopausal estrogen use and coronary atherosclerosis. Annals of Internal Medicine 1988; 108: 358–363
  • Tsai M. J., O'Malley B. W. Molecular mechanisms of action of sterioid/thyroid receptor superfamily members. Annual Review of Biochemistry 1994; 63: 451–486
  • Verweij C. L., Diergaarde P. J., Hard M., Pannekoek H. Full-length von Willebrand factor (vWF) cDNA encodes a highly repetitive protein considerably larger than the mature vWF subunit. EMBO Journal 1986; 5: 1839–1847
  • Wagner D. Cell biology of von Willebrand factor. Annual Reviews of Cell Biology 1990; 6: 217–246
  • Williams J. K., Adams M. R., Klopfenstein H. S. Estrogen modulates responses of atherosclerotic coronary arteries. Circulation 1990; 81: 1680–1687
  • Wu T. C. J., Wang L., Wan Y. J. Y. Detection of estrogen receptor messenger ribonucleic acid in human oocytes and cumulum-oocyte complexes using reverse transcriptase-polymerase chain reaction. Fertility and Sterility 1993; 59: 54–59
  • Yamashita S., Korach K. S. Modified immunohistochemical procedure for the detection of estrogen receptor in mouse tissues. Histochemistry 1989; 90: 325–330

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.